Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort
ConclusionsDespite our small sample population, HCT-CI/Age was more discriminative to identify patients with poor outcome that might benefit from intensified management strategies or other therapeutic approaches rather than allogeneic HCT.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Men | Statistics | Stem Cell Therapy | Stem Cells | Transplants